top of page
Logo of the Dry Eye Clinic – Dr. Abdalrahman Alabsi

Dry Eye Clinic
Dr. Abdalrahman Alabsi

Dry Eye Prevalence and Key Risk Factors

By Dr. Abdalrahman Alabsi – Ophthalmologist | Last reviewed: October 2026

​

Dry eye disease (DED) is one of the most common conditions in ophthalmology.

​

Prevalence of dry eye by diagnostic criteria

​

Based on dry eye symptoms only (patient complaints):

Prevalence ranges from about 7.3% in children aged 6–9 years to 31.6% in women aged 20–29 years. Among adults (40–80 years), rates are about 20% in men and 30% in women.

​

Based on dry eye symptoms (patient complaints) together with clinical signs of dry eye (examination and diagnosis):

Prevalence rises to 62.9% in women aged 20–29 years.

​

Based on clinical diagnosis without patient complaints:

Prevalence ranges from 1.0% in men over 80 to 15.3% in women aged 50–59 years.

​

Note: Women show a higher prevalence than men from the age of 10 onward.

​

Prevalence of meibomian gland dysfunction (MGD) – dysfunction of the tear-secreting oil glands

Meibomian gland dysfunction (MGD) is the main cause of evaporative dry eye (tear evaporation due to a deficient lipid layer).

​

Current statistics indicate that meibomian gland dysfunction may be present in 50% to 70% of dry eye cases, and up to 86% in some studies depending on diagnostic criteria and geographic region. It is about 71% in the Arab world and 76.1% in Saudi Arabia, making it the most common underlying cause of dry eye disease.

​

Risk factors for dry eye:

Risk factors are divided into modifiable and non-modifiable:

​

1. Non-modifiable risk factors:

Female sex and older age.

Autoimmune diseases: up to 90% of patients with Sjögren's disease have dry eye, and other autoimmune diseases such as rheumatoid arthritis, lupus, and scleroderma carry a twofold risk of dry eye.

​

2. Modifiable risk factors:

Contact lens wear.

Digital screen use.

Dry and air-conditioned environments.

Certain medications, especially those with anticholinergic effects, antihistamines (for allergies), some antidepressants, and isotretinoin (Roaccutane) for acne.

Skin and atopic conditions: such as rosacea, acne vulgaris, eczema, asthma, allergic diseases, and vernal keratoconjunctivitis.

Previous eye surgery: including all types of refractive surgery (surface laser/PRK, LASIK, FemtoLASIK, and SMILE) and cataract surgery.

modifiable-risk-factors-en-dryeyeksa.jpg

References

1. Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II Epidemiology Report. Ocul Surf. 2017;15(3):334-365. doi:10.1016/j.jtos.2017.05.003

2. Hassanzadeh S, Varmaghani M, Zarei-Ghanavati S, et al. Global Prevalence of Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis. Ocul Immunol Inflamm. 2021;29(1):66-75. doi:10.1080/09273948.2020.1755441

3. Helayel HB, Al Abdulhadi HA, Aloqab A, et al. Prevalence and Risk Factors of Dry Eye Disease among Adults in Saudi Arabia. Saudi J Med Med Sci. 2023;11(3):242-249. doi:10.4103/sjmms.sjmms_251_22

4. Stapleton F, Argüeso P, Asbell P, et al. TFOS DEWS III: Digest. Am J Ophthalmol. 2025;279:451-553. doi:10.1016/j.ajo.2025.05.040

bottom of page